Davis Polk and Uría Menéndez advised Banco Santander, S.A. in the deal. Banco Santander, S.A. executed its SEC-registered offering of $1.5 billion aggregate principal amount of 0.701%...
You must be a Standard 1 Year member to access this content.
Appleby acted as Cayman counsel to Gobi Acquisition Corp. in connection with its Initial Public Offering, while Davis Polk advised the joint book-running managers. Gobi Acquisition,...
You must be a Standard 1 Year member to access this content.
Goldman Sachs & Co. LLC acted as exclusive financial advisor, and Davis Polk & Wardwell LLP and Taft Stettinius & Hollister LLP acted as legal advisors...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised the sponsors and underwriters on the initial public offering of Nayuki Holdings Limited, assisted by Walkers and Davis Polk & Wardwell. Other...
You must be a Standard 1 Year member to access this content.
Dentons and Davis Polk advised GH Research PLC on the IPO. GH Research PLC executed its SEC-registered initial public offering of 11,499,999 ordinary shares for total...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the bookrunners, led by Deutsche Bank Securities Inc., on the offering. Hilton Grand Vacations Borrower Escrow LLC and Hilton Grand Vacations Borrower Escrow...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representative of the initial purchasers on the offering. LGI Homes, Inc. completed the offering of $300 million aggregate principal amount of its 4.000%...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the several underwriters in the IPO. Sprinklr, Inc. completed its $254 million initial public offering of 16,625,000 shares of Class A...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the underwriters in the offering. Theravance Biopharma, Inc. executed its $100.5 million public offering of ordinary shares. Theravance Biopharma’s ordinary shares are listed on the Nasdaq...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Clarivate Science Holdings Corporation on the offering. Clarivate Science Holdings Corporation, an indirect wholly-owned subsidiary of Clarivate Plc, executed a Rule 144A / Regulation S offering of $1 billion...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the underwriters on the offering, and Maples advised Missfresh Limited on the deal. Missfresh Limited completed its initial public offering of...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the underwriters in the offering. Summit Healthcare Acquisition Corp. completed its initial public offering of 200,000,000 units for aggregate proceeds of $200 million. Each...
You must be a Standard 1 Year member to access this content.
